Computational Studies: Cisplatin

作者: Yogita Mantri , Mu-Hyun Baik

DOI: 10.1002/0470862106.IA625

关键词:

摘要: Cisplatin is one of the most successful anticancer drugs currently in use. Since discovery its antitumor activity over three decades ago, intense research has been carried out to uncover details cytotoxic and design analogs with fewer side effects. Computational studies have complemented experimental this effort. Much early computational effort was dedicated understanding hydrolysis process cisplatin that leads activated drug. With mounting evidence DNA primary target drug a simultaneous increase computing power, later theoretical aimed explore atomistic cisplatin–DNA interactions. Currently, both quantum mechanical molecular methods are being used study thermodynamics kinetics not only complexes, but also other complexes such as Pt(II)-based analogs, transition metal binding organic molecules. Despite these remarkable achievements, much work still remains be done, experimentally computationally, especially elucidating role repair enzymes modulating agents. Keywords: cisplatin; cisplatin–DNA interactions; platinum drugs; DNA-binding drugs; molecular modeling; molecular dynamics; density functional theory; QM/MM

参考文章(85)
Kristy Cochran, Gareth Forde, Glake A. Hill, Leonid Gorb, Jerzy Leszczynski, cis-Diamminodichloronickel and Its Interaction With Guanine and Guanine-Cytosine Base Pair Structural Chemistry. ,vol. 13, pp. 133- 140 ,(2002) , 10.1023/A:1015752431266
T. Sumizawa, S.-I. Akiyama, Z.-S. Chen, T. Furukawa, Resistance to cisplatin. Anti-cancer Drug Design. ,vol. 14, pp. 143- 151 ,(1999)
Barnett Rosenberg, Earl Renshaw, Loretta Vancamp, John Hartwick, Jaroslav Drobnik, Platinum-Induced Filamentous Growth in Escherichia coli1 Journal of Bacteriology. ,vol. 93, pp. 716- 721 ,(1967) , 10.1128/JB.93.2.716-721.1967
Eric D. Scheeff, James M. Briggs, Stephen B. Howell, Molecular Modeling of the Intrastrand Guanine-Guanine DNA Adducts Produced by Cisplatin and Oxaliplatin Molecular Pharmacology. ,vol. 56, pp. 633- 643 ,(1999) , 10.1124/MOL.56.3.633
Ronald S. Go, Alex A. Adjei, Review of the Comparative Pharmacology and Clinical Activity of Cisplatin and Carboplatin Journal of Clinical Oncology. ,vol. 17, pp. 409- 409 ,(1999) , 10.1200/JCO.1999.17.1.409
Uta-Maria Ohndorf, Mark A. Rould, Qing He, Carl O. Pabo, Stephen J. Lippard, Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins. Nature. ,vol. 399, pp. 708- 712 ,(1999) , 10.1038/21460
Elena Tornaghi, Wanda Andreoni, Paolo Carloni, Jürg Hutter, Michele Parrinello, Carboplatin versus cisplatin: density functional approach to their molecular properties Chemical Physics Letters. ,vol. 246, pp. 469- 474 ,(1995) , 10.1016/0009-2614(95)01099-2
John C. Dewan, Binding of the antitumor drug cis-diamminedichloroplatinum to crystalline tRNAPhe at 6-.ANG. resolution Journal of the American Chemical Society. ,vol. 106, pp. 7239- 7244 ,(1984) , 10.1021/JA00335A063